Skip to main content

Closed

INCY: Incyte Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+14.8% / yr

Operating margin31.6%

ROIC24.6%

Financially safe

Strong

Debt / equity0.01×

Interest coverage790.6×

Current ratio4.66×

Valuation

Unrated

P/E ratio14.7×

Incyte Corporation

INCYNASDAQ Global Select·USD·Closed

Incyte Corporation

INCYNASDAQ·USD·Closed

$119.52

−2.82%

$119.52

−$3.47 (2.82%)

52W Range

78thpctl

Volume

1.01×avg

Mkt Cap

24.23BUSD

P/E

14.7TTM

Div Yield

–ann

52W Range

78thpctl

Volume

1.01×avg

Market Cap

24.23BUSD

P/E Ratio

14.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings